Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Wan

Showing results (151-160 of 157) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 157 results.
NPJ Parkinson'S Disease|September 1, 2023
Mutational spectrum and clinical features of GBA1 variants in a Chinese cohort with Parkinson's diseaseYangjie Zhou, Yige Wang, Juan Wan, et al.
Gut|May 21, 2026
Blocking MOXD1-derived ACOX1 peroxisome trafficking suppresses metabolic dysfunction-associated steatohepatitisMei Li, Jinquan Zhang, Yunfan Yang, et al.
Gut|November 27, 2025
Discovery of a carboxyl fullerene derivative as a new lipid droplet regulator inhibiting MASLDToujun Zou, Juan Wan, Rufang Liao, et al.
Science Translational Medicine|February 14, 2024
Multispecies transcriptomics identifies SIKE as a MAPK repressor that prevents NASH progressionLan Bai, Weiyi Qu, Xu Cheng, et al.
The Journal of Clinical Investigation|September 2, 2025
Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction-associated steatohepatitisXiao-Jing Zhang, Jiajun Fu, Xu Cheng, et al.
Science Translational Medicine|December 15, 2021
A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaquesXiao-Jing Zhang, Yan-Xiao Ji, Xu Cheng, et al.
NPJ Parkinson'S Disease|March 28, 2026
The genetic spectrum of LRRK2 variants in Parkinson's disease: findings from a large Chinese cohortJuan Wan, Hongxu Pan, Dong Chang, et al.
Pageof 16

Showing results (151-160 of 157) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
NPJ Parkinson'S Disease|September 1, 2023
Mutational spectrum and clinical features of GBA1 variants in a Chinese cohort with Parkinson's diseaseYangjie Zhou, Yige Wang, Juan Wan, et al.
Gut|May 21, 2026
Blocking MOXD1-derived ACOX1 peroxisome trafficking suppresses metabolic dysfunction-associated steatohepatitisMei Li, Jinquan Zhang, Yunfan Yang, et al.
Gut|November 27, 2025
Discovery of a carboxyl fullerene derivative as a new lipid droplet regulator inhibiting MASLDToujun Zou, Juan Wan, Rufang Liao, et al.
Science Translational Medicine|February 14, 2024
Multispecies transcriptomics identifies SIKE as a MAPK repressor that prevents NASH progressionLan Bai, Weiyi Qu, Xu Cheng, et al.
The Journal of Clinical Investigation|September 2, 2025
Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction-associated steatohepatitisXiao-Jing Zhang, Jiajun Fu, Xu Cheng, et al.
Science Translational Medicine|December 15, 2021
A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaquesXiao-Jing Zhang, Yan-Xiao Ji, Xu Cheng, et al.
NPJ Parkinson'S Disease|March 28, 2026
The genetic spectrum of LRRK2 variants in Parkinson's disease: findings from a large Chinese cohortJuan Wan, Hongxu Pan, Dong Chang, et al.
Pageof 16